Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 139.92B, Pfizer(PFE) trades at $24.55. The stock has a price-to-earnings ratio of 18.59 and currently yields dividends of 7.09%.
During the trading session on 2026-07-15, Pfizer(PFE) shares reached a daily high of $24.56 and a low of $24.25. At a current price of $24.55, the stock is +1.2% higher than the low and still -0.0% under the high.
Trading volume for Pfizer(PFE) stock has reached 2.76M, versus its average volume of 44.4M.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
PFE News
...
Pfizer stock sits in an awkward middle ground for valuation right now, with a roughly 21% share price decline over five years set against checks that suggest th...
This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...
Analyst ratings
62%
of 29 ratingsMore PFE News
Key Points Pfizer's yield has fluctuated over the years due to its volatile share price. Its recent earnings numbers suggest the dividend is safe, but there i...
Key Points Voluntary pricing deals reduce uncertainty for major drugmakers. Drug pricing pressure won't affect every pharmaceutical company equally. Strong p...
Pfizer (PFE) closed the latest trading day at $26.61, indicating a +0.3% change from the previous session's end. The stock's performance was ahead of the S&P 50...
BMO Capital lowered the firm’s price target on Pfizer (PFE) to $30 from $34 and keeps an Outperform rating on the shares as part of a broader research note prev...
FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) for adult patients with muscle-invasive bladder cancer. The regimen is cleared for...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has...
Humans are very bad at taking medications. By some estimates, adherence to long-term chronic medication treatment plans is only around 50%. This is a big issue...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.